The U.S. House blocked the DOD from buying more costly substitutes for petroleum-based fuels
by
Robert F. Service and Elizabeth Pennisi
New technology could simplify and accelerate genome analysis
Experts answer your questions on the latest in solar cell technology
Experts answer your questions about the failures and future of the green energy revolution
by
Science News Staff
Plus more highlights from Science's policy blog, ScienceInsider
by
Science News Staff
Plus more from Science's policy blog, ScienceInsider
by
Science News Staff
Plus more from Science's policy blog, ScienceInsider
by
Science News Staff
Plus more, from Science's new policy blog, ScienceInsider
by
Phil Berardelli
Old-fashioned irrigation saves water
by
Jennifer
Couzin
Company that mines the DNA of Iceland's population seeks merger to survive financial crisis
by
Martin Enserink
Manufacturing snafu underscores vulnerability of vaccine supplies
by
Helen Fields
Museum tries to price a very special specimen
by
David Malakoff
Science societies defend publishing practices
by
Andrew Lawler
Private money, multidisciplinary approach for new research institute
New California consortium hopes to make pharmaceutical research pay
by
Alicia Ault
Global report foresees industry profitability by 2010
by
David Malakoff
Court says patent for blockbuster anti-inflammatory drugs is invalid
by
Dennis Normile
Japanese court rules that patent for blue LED belongs to inventor's employer
by
Science News Staff
Report urges leeway for the developing world
by
Charles Seife
MIT used a cartoon heroine knock-off to win Army contract
by
David Malakoff
Festo decision reverses controversial ruling on copycat inventions
Deal frees Affymetrix to focus on other problems
by
Charles Seife
Proposed methods may already have been cracked
by
John MacNeil
Multiyear sentences for drug company exec and nurse for scam to inflate pharmaceutical stock
Academic scientists are stewing about a recently issued patent that gives a private company the rights to CCR5, a human gene that plays a key role in HIV infection. The...
by
Laura Helmuth
After 5 years of bitter negotiations, delegates from 130 countries finally hammered out a global treaty that will govern the trade of genetically modified organisms (GMOs). The treaty formalizes the...
by
Gretchen Vogel
A U.S. company has received two British patents that appear to grant it commercial rights to human embryos created by cloning. The precedent-setting patents, issued last week on the cloning...
A new agreement cuts away some of the red tape snarling cancer research. The policy, announced by the National Institutes of Health (NIH) on 19 January, allows NIH-funded scientists doing...
by
Martin Enserink
Two powerhouses in the life sciences, U.S. Monsanto and U.S.-Swedish Pharmacia & Upjohn, yesterday announced that they plan to merge, creating a new pharmaceutical company with a market capitalization of...
by
Marcia Barinaga
SAN FRANCISCO--A bitter episode in biotech history was finally put to rest last week when biotech pioneer Genentech agreed to pay the University of California (UC) $200 million to settle...
by
Marcia Barinaga
One of the longest patent fights in biotech history may at last be over. Today, the Los Angeles Times reported that Genentech Inc. of South San Francisco had agreed to...
by
Robert Koenig
BERN, SWITZERLAND--Austria, whose life-sciences researchers have tended to work in the shadows of their colleagues in neighboring Germany and Switzerland, is now making a move to attract top-flight scientists with...
by
Martin Enserink
Over the last 2 decades, scientists have witnessed the gradual erosion of a cornerstone of scientific progress: the free exchange of research materials like reagents, cells, and animals. The invasion...
A former researcher at Genentech Inc. of South San Francisco has testified that he secretly removed a bacterial clone from a lab he had recently left at the University of...
Geneticists are about to get a brand new tool, thanks to a remarkable public-private venture announced today. Ten large, fiercely competitive pharmaceutical companies and the Wellcome Trust, a British charity,...
by
Helen Gavaghan
Elsevier Science of the Netherlands has bought Cell Press, publisher of the journal Cell and its sister publications Immunity, Neuron, and Molecular Cell. Clearly regarding the acquisition as a coup,...
by
David Malakoff
A federal judge has ruled that the National Park Service must complete an environmental review before it can move ahead with a controversial bioprospecting contract. Government analysts say the ruling...
by
Helen Gavaghan
HEBDEN BRIDGE, U.K.--In a bill sent to Parliament on Wednesday, the British government revealed its long-awaited plan to establish an independent Food Standards Agency (FSA), charged with guarding food safety....
WASHINGTON, D.C.--A battle is brewing over a new plant technology that allows companies to ensure that genetically modified plants produce sterile seeds--a feat that will keep farmers coming back for...
A group of scientists and funders last week gave an initial thumbs-up to a new strategy for bankrolling what could amount to a $30-million-a-year program to develop drugs against malaria....